Almonertinib
Drug timelines are a Plus or Pro feature.
34 regulatory and trial events tracked for Almonertinib, covering 2020-07-02 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC [Phase 2]